Latest investigations into retatruptide peptide reveal significant potential for managing weight and type 2 diabetes mellitus. The compound, a dual agonist of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide, looks to present improved body mass and glucose control versus e